High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis

CONCLUSIONS: Fractionated HDR monotherapy is associated with high rates of disease control and low rates of toxicity. Future studies are needed to better define the value of this treatment modality relative to other options.PMID:34484350 | PMC:PMC8407258 | DOI:10.5114/jcb.2021.108590

Source: Journal of Contemporary Brachytherapy - September 6, 2021 Category: Cancer & Oncology Authors: Eric M Anderson Sungjin Kim Howard M Sandler Mitchell Kamrava Source Type: research